Market closedNon-fractional
FibroBiologics/FBLG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About FibroBiologics
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Ticker
FBLG
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Houston, United States
Employees
10
Website
www.fibrobiologics.com
FibroBiologics Metrics
BasicAdvanced
$170M
Market cap
-
P/E ratio
-$0.78
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$170M
Financial strength
Current ratio
0.638
Quick ratio
0.583
Long term debt to equity
-33.057
Total debt to equity
-54.569
Interest coverage (TTM)
-629.63%
Management effectiveness
Return on equity (TTM)
573.36%
Valuation
Price to book
-40.09
Price to tangible book (TTM)
-40.09
Price to free cash flow (TTM)
-15.2
Growth
Earnings per share change (TTM)
141.60%
FibroBiologics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$8.4M
-13.40%
Profit margin
0.00%
NaN%
FibroBiologics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for FibroBiologics stock?
FibroBiologics (FBLG) has a market cap of $170M as of July 27, 2024.
What is the P/E ratio for FibroBiologics stock?
The price to earnings (P/E) ratio for FibroBiologics (FBLG) stock is 0 as of July 27, 2024.
Does FibroBiologics stock pay dividends?
No, FibroBiologics (FBLG) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next FibroBiologics dividend payment date?
FibroBiologics (FBLG) stock does not pay dividends to its shareholders.
What is the beta indicator for FibroBiologics?
FibroBiologics (FBLG) does not currently have a Beta indicator.
Buy or sell FibroBiologics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.